Skip to main content

Remedy-Pharmaceuticals-logo

Remedy Pharmaceuticals, a company focused on the development and commercialization of CIRARA™, a breakthrough drug for treating acute central nervous system conditions, announced that a prospective multi-center open-label pilot study of CIRARA in patients with acute traumatic cervical spinal cord injuries. 

{iframe}http://www.umventures.org/news/remedy-pharmaceuticals-initiates-phase-2a-study-cirara™-spinal-cord-injury{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.